This post was just published on ZYX Buy Change Alert. Algorithms at The Arora Report have been detecting smart money lightly stepping into MYL throughout the morning. MYL stock is up significantly more than others in the group taking their normal beta into account after falling less than others in the group
This post was just published on ZYX Buy Change Alert. All generic drug manufacturers are falling on the news that U. S. prosecutors are starting an investigation on price collusion among generic drug manufacturers. Of note is that MYL has the least amount of loss among the stocks in the group on
Since the Feb. 18 announcement that Actavis would acquire Forest Laboratories for about $25 billion, which caused Forest Laboratories stock to leap higher, Mylan stock has been moving up strongly in sympathy on speculation it, too, could be bought. However, the Smart Money has been selling Mylan into the strength, and with
Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be acquired by a larger player. Cubist has received upgrades from several brokers. At present, cubist satisfies only three screens of the ZYX Change Method. We will issue an actionable signal in